Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs051250180Recruiting
Randomised trial of octreotide in duodenal papillary cancer, Duodenal adenoma (DA) and ampullary adenocarcinoma (2 arms). Started Mar 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs051250180.